Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality.

Xin LuXue WangYanxia GaoJoseph Harold WallineShiyuan YuZengzheng GeMubing QinHuadong ZhuYun Li

Published in: ESC heart failure (2022)

Cardiogenic shock patients treated with norepinephrine were associated with significantly increased short-term mortality, while no significant difference was found on long-term survival rates. Future trials are needed to validate and explore this association.

Keyphrases

end stage renal disease
cardiovascular events
ejection fraction
newly diagnosed
risk factors
prognostic factors
peritoneal dialysis
type diabetes
cardiovascular disease